Bausch Is Adding to Glenview’s Woes

Larry Robbins mixes up the hedge fund’s health-care holdings — but can’t stop the bleeding.

Michelle Celarier August 20, 2020

Larry Robbins, CEO of Glenview Capital Management.

(Kholood Eid/Bloomberg)

Bausch Health Cos., that Canadian company formerly known as Valeant Pharmaceuticals International that is still struggling with heavy debt, is now one of the biggest positions of Larry Robbins’s Glenview Capital Management, according to recent securities filings.But Bausch, a shadow of its former self, seems

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.12.03 build:2025-12-12 Login